The Global Artificial Intelligence for Healthcare Applications market report enumerates highly classified information portfolios encompassing multi-faceted industrial developments with vivid references of market share, size, revenue predictions along with overall regional outlook. The report illustrates a highly dependable overview of the competition isle, with detailed assessment of business verticals. Post a systematic research initiative and subsequent evaluation overview, the global Artificial Intelligence for Healthcare Applications market mimicking its past growth performance is anticipated to strike a flourishing ROI and is therefore more likely to be on the favorable growth curve in the coming years. This versatile report describing the global Artificial Intelligence for Healthcare Applications market has entailed a range of information portfolios that have been segregated into indispensable and additional information streams that have been represented in the form of tables, pie-charts, graphs and the like to align with maximum reader understanding.

A detailed study accumulated to offer Latest insights about acute features of the Healthcare Artificial Intelligence market. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. The report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis. The Global Healthcare Artificial Intelligence Market research report displays the market size, share, status, production, cost analysis, and market value with the forecast period 2019-2024.

I am a MAKER, for the hearts of the dream." So goes a rallying cry carved in giant letters on the wall of a warehouse in Shekou, a seaside enclave near Hong Kong. Many of China's most promising entrepreneurs flocked there recently for a conference organised by TechCrunch, a technology publisher from Silicon Valley. Yet Baidu, Alibaba and Tencent--established Chinese internet giants collectively known as the BAT--were overshadowed by upstarts such as Didi Chuxing, a ride-hailing firm that chased America's Uber away from China, and Ofo, a bike-sharing startup that is going global. Upgrade your inbox and get our Daily Dispatch and Editor's Picks. They are part of a new wave of inventive young firms emerging from China. A few years ago, Chinese innovation meant copycats and counterfeits.

If you didn't know what the word "microbiome" meant, you wouldn't be chastised for thinking that it's just some boring medical terminology that when explained to you, you'd be none the wiser for knowing. As we found out, that couldn't be further from the truth. We've come across the word "microbiome" a few times, but only when we saw the below chart from CB Insights did we really want to start exploring the world of the "microbiome": So there are 24 different startups "targeting" the microbiome? There's clearly some opportunity here and we want to start out by fully understanding what the microbiome is and why it matters to all these startups. First, let's take the textbook definition of "microbiome" from Google: This is where we started thinking to ourselves about all the bacteria that lives in your gut.

Trans-Pacific View author Mercy Kuo regularly engages subject-matter experts, policy practitioners, and strategic thinkers across the globe for their diverse insights into the U.S. Asia policy. This conversation with Eleonore Pauwels – Director of Biology Collectives and Senior Program Associate, Science and Technology Innovation Program at the Wilson Center in Washington D.C. – is the 104th in "The Trans-Pacific View Insight Series." With large public and private investments inland and in the U.S., China plans to become the next AI-Genomics powerhouse, which indicates that these technologies will soon converge in China. China's ambition is to lead the global market for precision medicine, which necessitates acquiring strategic technological and human capital in both genomics and AI. A sharp blow in this U.S.-China competition happened in 2013 when BGI purchased Complete Genomics, in California, with the intent to build its own advanced genomic sequencing machines, therefore securing a technological knowhow mainly mastered by U.S. producers.

China is pouring resources into artificial intelligence to nurture world-class companies that can compete with the likes of Google and IBM in building intelligence machines.(AP In China's quest to shed its reputation as a land of copycats, the world's second-biggest economy is pouring resources in to the hottest area in technology innovation: artificial intelligence. With the goal of nurturing world-class companies that can compete with the likes of Google and IBM in building intelligent machines, the Chinese leadership singled out AI as a key area of development in a report released during the National People's Congress in March. Soon after, the country's biggest technology companies -- Alibaba, Baidu and Tencent -- announced plans for AI laboratories and projects worth billions of dollars. Many analysts believe AI is one area China can excel.

We've talked before about the prospects of artificial intelligence (AI) and how it will likely disrupt things like we've never seen before with some estimates predicting that up to 80% of all service jobs will be impacted. Healthcare is one area where AI is receiving a good chunk of funding. We looked before at one example of an artificial intelligence company called Enlitic that uses machine learning technology to read X-rays better than a human radiologist who makes $286,000 a year on average. There are actually quite a few artificial intelligence companies in healthcare and CB Insights recently identified 65 of them at various stages of funding. Founded just last year, Chinese company iCarbonX has taken in nearly $200 million in funding from investors that include the $200 billion Chinese internet giant Tencent.

China is pouring resources into artificial intelligence to nurture world-class companies that can compete with the likes of Google and IBM in building intelligence machines.(AP In China's quest to shed its reputation as a land of copycats, the world's second-biggest economy is pouring resources in to the hottest area in technology innovation: artificial intelligence. With the goal of nurturing world-class companies that can compete with the likes of Google and IBM in building intelligent machines, the Chinese leadership singled out AI as a key area of development in a report released during the National People's Congress in March. Soon after, the country's biggest technology companies -- Alibaba, Baidu and Tencent -- announced plans for AI laboratories and projects worth billions of dollars. Many analysts believe AI is one area China can excel.

You may have heard us talk about CB Insights before. What CB Insights does is provide a huge database of private company information that is collected using artificial intelligence. They then sell this data to 100s of firms that need accurate data. Sure, you can go pay $50 a month to Crunchbase and get private company data but you're getting crowdsourced data as opposed to data collected by AI agents and cleansed by people that don't live in Mumbai. We've talked about a fair number of these companies already, and we're already sharpening our pencils to make sure that we profile each and every one of them as fast as our little big hands can type.

Jun Wang, founder of digital biotechnology firm iCarbonX, showcases the Meum app that will use reams of health data to provide customized medical advice. One of China's most intriguing biotechnology companies has fleshed out an earlier quixotic promise to use artificial intelligence (AI) to revolutionize health care. The Shenzhen firm iCarbonX has formed an ambitious alliance with seven technology companies from around the world that specialize in gathering different types of health-care data, said the company's founder, Jun Wang, on 5 January at the Digital Life Summit, which was hosted by iCarbonX. The alliance will use algorithms to analyse reams of genomic, physiological and behavioural data and provide customized health and medical advice directly to consumers through an app. The announcement was a long-anticipated debut for iCarbonX, which Wang founded in October 2015 shortly after he left his leadership position at China's genomics powerhouse, BGI, also in Shenzhen.